Nucala 100 MG/ML auto-injectorml
Ended Awarded Last action
- Contract number
- SPE2DR26FCYY7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,455
Award facts
- Contract value 100% obligated
- $15,454.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nucala 100 mg/mL auto-injector medication. The delivery order, valued at $15,454.64 with a completion date of December 2, 2025, was awarded without set-aside designation on December 1, 2025. This award falls under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a single-award contract valued at $499.999 billion through December 31, 2036, that authorizes DLA to issue delivery orders for comprehensive pharmaceutical products and medical consumables supporting Department of Defense healthcare operations globally.
As a regional prime vendor contractor within the $30.3 billion PPV-G GEN V acquisition strategy, DMS Pharmaceutical Group has demonstrated substantial capability in supplying specialized pharmaceutical products including biologics, branded and generic prescription medications, vaccines, and specialty pharmaceuticals to military healthcare facilities. The company's established performance on numerous delivery orders since October 2025 reflects its capacity to fulfill diverse medical supply requirements of the federal military medical system. No subcontractors are identified in the award documentation, with DMS Pharmaceutical Group serving as the sole source of supply under this delivery order arrangement.
Quick answers
Who was awarded contract SPE2DR26FCYY7?
SPE2DR26FCYY7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26FCYY7 worth?
The government has obligated $15,455 on SPE2DR26FCYY7.
Is contract SPE2DR26FCYY7 an order under another contract?
Yes. SPE2DR26FCYY7 is a delivery order under SPE2DR25D9127, an indefinite delivery contract.
Was contract SPE2DR26FCYY7 competed?
The extent of competition for SPE2DR26FCYY7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award